Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists. Read more about Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists.
Trends, utilization, and immediate perioperative complications of urethroplasty in the United States: data from the national inpatient sample 2000-2010. Read more about Trends, utilization, and immediate perioperative complications of urethroplasty in the United States: data from the national inpatient sample 2000-2010.
Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result. Read more about Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result.
Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer. Read more about Understanding the relationship between tumor size, gland size, and disease aggressiveness in men with prostate cancer.
Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop. Read more about Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop.
Metabolic syndrome as a predictor for postoperative complications after urologic surgery. Read more about Metabolic syndrome as a predictor for postoperative complications after urologic surgery.
A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Read more about A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer.
